01 January 2002
Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases.
Robert Debski, Jan Styczyński, Mariusz Wysocki, Sylwia Kołtan, Violetta Swiatkiewicz, Andrzej Kołtan, Anna Balcar-BorońMed Sci Monit 2002; 8(4): CR274-279 :: ID: 420868
Abstract
BACKGROUND: Viral hepatitis C in children is milder than in adults. Patientswith tumors, because of immune deficits, seem to be at risk of rapid liver disease progression. Littleis known about the course of HCV and dual HBV-HCV infections in such patients. MATERIAL/METHODS: Thestudy assessed clinical courses of HCV and dual HBV-HCV infections in 249 children with tumors aged 1-18years, divided into four groups: with HCV infection - 53, HBV-HCV infection - 53, HBV only - 33 and infection-free- 110. RESULTS: Hepatitis C was often chronic - in 83.3% of patients with HCV and 77.3% of those withdual infection. Over 80% had no jaundice. Mean AlAT activity was the highest in the HCV group (149.2I202.7IU/l), lower in the dual infection group (123.3I148.1 IU/l; p<0.02), and the lowest in HBV (92.7±152.9 IU/l). Transaminasemia course in patients with HCV and dual HBV-HCV infections was most frequently fluctuating (50.9% and 45.3%, respectively). 52.8% of children with HCV demonstrated no advanced inflammatory lesions with invasion of the
lamina limitans, no marked fibrosis, and minimum changes in descriptive classification. In 92.3% of children with dual infections, inflammatory activity was mild or mean, with no fibrosis
in 61.5%, and persistent chronic inflammation predominant in descriptive classification(46.1%).
Conclusions: HCV and HBV-HCV infections in children with neoplastic diseases tend to take chronic forms, but their clinical course is mild with signs of severe inflammatory activity or hepatic
stroma remodeling observed on histopathology.
Keywords: Adolescent, Alanine Transaminase, bilirubin, Biopsy, Child, Child, Preschool, Comparative Study, Disease Progression, Follow-Up Studies, Hepatitis B, Hepatitis B, Chronic, Hepatitis C, Hepatitis C, Chronic, Incidence, Leukemia, Liver, Liver Cirrhosis, Neoplasms, Severity of Illness Index
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
05 Mar 2024 : Clinical Research
Role of Critical Shoulder Angle in Degenerative Type Rotator Cuff Tears: A Turkish Cohort StudyMed Sci Monit In Press; DOI: 10.12659/MSM.943703
06 Mar 2024 : Clinical Research
Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...Med Sci Monit In Press; DOI: 10.12659/MSM.943797
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952